The title of Chief Commercial Officer is everywhere; the capability behind it is rare. In life sciences technology, the gap between an adequate CCO and an exceptional one is often the gap between a flat year and a breakout one.
A great CCO is not simply a senior salesperson. They own the entire commercial engine: positioning, pricing, partnerships, marketing and sales — and they translate a complex scientific or technical proposition into a story that buyers, boards and investors all understand. In our experience placing commercial leaders across the sector, five qualities consistently separate the best from the rest.
Strong CCOs design the commercial model rather than just working it harder. They make deliberate choices about segments, channels, pricing and partnerships, and they build the operating rhythm — forecasting, pipeline discipline, deal governance — that makes growth repeatable rather than heroic. The best are equally comfortable in a customer meeting and a board pack.
“An exceptional CCO is a translator: turning science into value the market will pay for, and turning market signal into strategy the board will back.”
Three further traits compound that foundation. Narrative: the ability to make a complex proposition feel inevitable to a sceptical buyer. Cross-functional gravity: the trust to align product, medical, marketing and finance behind one commercial plan. And talent magnetism: the best CCOs attract and keep A-players, because commercial results are ultimately a team output.
Interviews reward articulate candidates; they do not always reveal effective ones. We assess commercial leaders against evidence: how they have built a model, not just hit a number; how they have navigated a regulated, multi-stakeholder sale; and how the teams they led performed after they left. References with former direct reports are often more revealing than those with former managers.
Helping deliver talent that drives growth across the life sciences ecosystem.